Summary

dangerorchid91 Users

  • Cost-effectiveness Evaluation associated with Robotic-assisted Lobectomy pertaining to Non-small Mobile United states.
Offline Offline
Posts:
0 (0 per day)
Age:
N/A
Date Registered:
2025-07-16, 14:12:46
Local Time:
2025-07-18, 11:32:09
Last Active:
2025-07-16, 18:58:48
Signature:
Majority of the respondents used biologics in less than 2 cases per month. Secukinumab was the most common biologic used followed by etanercept. The f